In addition, through the research method of network pharmacology, we analyzed and found that the mechanism of action of FXHJ in the treatment of heart failure may also be related to the toll-like receptor signaling pathway, VEGF signaling pathway, and NF-kappa B signaling pathway. Here, VEGFA is linked to heart failure.